Key Takeaways:
- Moolec Science has received USDA-APHIS regulatory approval for its genetically engineered peas, marking the company’s third USDA regulatory clearance in 18 months.
- The genetically engineered peas produce bovine meat proteins, specifically bovine myoglobin, which significantly boosts iron content.
- This development positions Moolec as a leader in Molecular Farming with approvals for safflower, soybean, and pea in the U.S.
- The approval paves the way for expanded field trials, seed scaling, and commercialization.
Regulatory Clearance for Genetically Engineered Peas
Moolec Science SA (NASDAQ: MLEC), a pioneer in Molecular Farming technology, announced that it has received regulatory clearance from the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (USDA-APHIS) for its genetically engineered (GE) peas. This approval allows Moolec’s GE peas, which produce iron through bovine meat proteins, to advance into the U.S. market. The USDA’s Regulatory Status Review (RSR) deemed the GE peas safe and not subject to plant pest regulations, marking the company’s third regulatory approval in just 18 months.
Milestone for Moolec Science
According to Gastón Paladini, CEO and Co-Founder of Moolec Science, this milestone solidifies the company’s leadership in Molecular Farming. “With USDA approval for our GE pea, Moolec has now secured regulatory clearance for all of our key crops in the U.S.: safflower, soybean, and pea,” Paladini said. The company’s progress in securing approvals for its safflower and soybean products, GLASO™ and Piggy Sooy™ respectively, further demonstrates its growing influence in the market.
Innovation in Food Production
Moolec’s GE peas are designed to produce bovine myoglobin, a protein that enhances iron content, offering a plant-based alternative to traditional meat sources. This innovation is expected to make an impact in the food ingredient market and the broader $65 billion pea industry. By offering iron-rich, plant-based protein, Moolec aims to address the growing demand for nutritious and sustainable food alternatives.
Chief Science Officer Amit Dhingra highlighted the significance of this regulatory approval, noting, “The USDA-APHIS Regulatory Status Review for pea marks a historic development. It validates Moolec’s strategic approach and exemplifies our commitment to advancing sustainable food production through science and innovation.”
Commitment to Safety and Sustainability
The USDA-APHIS approval process, as outlined in regulation 7 CFR part 340, ensures that genetically engineered crops do not pose an increased plant pest risk compared to their non-GE counterparts. Moolec has also developed an Identity Preservation Program to maintain sustainable farming practices and uphold product quality.
This approval opens the door for expanded field trials, seed scaling, and potential commercialization. As demand for science-based ingredients continues to grow, Moolec Science is positioned to play a key role in driving innovation in the food and agriculture sectors.
Moolec Science Latest News
Secures $30M in Funding (2023/10/18)
Moolec Science, a leader in food ingredient technology, has secured $30 million in funding through strategic partnerships. The company will issue a convertible note to Grupo Insud, with a principal amount of $21 million, against a cash payment of $10 million and in-kind contributions. Additionally, Moolec has secured a supply agreement with Bioceres Crop Solutions, ensuring the supply of 15,000 tons of HB4® soybeans produced under regenerative agricultural practices. The capital raised will strengthen Moolec’s financial position and accelerate its business model.
Moolec Science Secures $50M Financing From Nomura Securities (2023/04/18)
Moolec Science SA (NASDAQ: MLEC) and Nomura Securities International, Inc. entered a Share Purchase Agreement for a committed equity financing facility recently. Per the terms of the agreement, the firm has the option to sell to Nomura its ordinary shares for an amount not exceeding $50 million in total gross purchase price over a 36-month period.
GLA Safflower Plants Receive USDA-APHIS Approval (2023/04/06)
The Animal and Plant Health Inspection Service (APHIS) of the U.S. Department of Agriculture (USDA) has determined that Moolec’s GLA safflower plants do not pose a greater plant pest risk than non-genetically engineered safflower plants, according to Moolec Science SA (NASDAQ: MLEC), a Molecular Farming food ingredient company.
Rings Nasdaq Bell After Business Combination (2023/01/17)
Moolec Science, a pioneer in Molecular Farming, completed a business combination with LightJump Acquisition Corporation and became a Luxembourg-based company. Its ordinary shares and warrants will trade on the Nasdaq Capital Market under the symbols “MLEC” and “MLECW”. The company’s CEO, Gastón Paladini, expressed his excitement for the opportunities ahead to improve food security and sustainability through cutting-edge technology. The company will ring the closing bell at Nasdaq on January 17, 2023, to celebrate the commencement of trading.
1 Comment